Synthesis and Biological Evaluation of a New Polymeric Conjugate and Nanocarrier with Osteotropic Properties
Open Access
- 19 January 2012
- journal article
- review article
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 3 (1), 79-99
- https://doi.org/10.3390/jfb3010079
Abstract
Bone-seeking (osteotropic) drug delivery systems (ODDS) represent an interesting solution for targeting different types of drugs to the bones. In particular, anticancer and antibacterial agents could take advantage of such therapeutic strategy. We have recently developed an innovative approach to this aim: a new osteotropic biomaterial was prepared, based on the conjugation of a poly(lactide-co-glycolide) (PLGA) with the bisphosphonate drug alendronate (PLGA-ALE); its hemo- and cytocompatibility were verified. Starting with this copolymer, an osteotropic nanoparticle system (NP) was produced for the targeted delivery of antineoplastic drugs to osteolytic bone metastases; in particular, doxorubicin was tested as a model drug. The in vitro and in vivo results of the new ODDS are validated in this article. All the experimental data confirmed that the drug retained its activity after loading in the PLGA-ALE NP; they can be thus considered a new promising strategy for active targeting of drugs to bone tissues in different pathological situations.Keywords
This publication has 41 references indexed in Scilit:
- The Effect of Poly( d , l -Lactide-co-Glycolide)-Alendronate Conjugate Nanoparticles on Human Osteoclast PrecursorsJournal of Biomaterials Science, Polymer Edition, 2012
- Active targeting strategies for anticancer drug nanocarriers.Current Drug Delivery, 2012
- Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterialsEuropean Journal of Medicinal Chemistry, 2012
- Targeting Bone Metastases with a Bispecific Anticancer and Antiangiogenic Polymer–Alendronate–Taxane ConjugateAngewandte Chemie-International Edition, 2009
- Biocompatibility of poly(d,l-lactide-co-glycolide) nanoparticles conjugated with alendronateBiomaterials, 2008
- Exploiting the enhanced permeability and retention effect for tumor targetingDrug Discovery Today, 2006
- The potential risks of nanomaterials: a review carried out for ECETOCParticle and Fibre Toxicology, 2006
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- The systemic treatment of bone metastases.1995
- Scanning electron microscopy in bone pathology: review of methods, potential and applications.1986